Prognostic indicators in node-negative early stage breast cancer
- 1 May 1992
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 92 (5) , 539-548
- https://doi.org/10.1016/0002-9343(92)90751-v
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The natural history of breast cancer: Implications for a screening strategyInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Indicators of Prognosis in Node-Negative Breast CancerNew England Journal of Medicine, 1990
- Adjuvant Therapy of Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast CancerNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesCancer, 1989
- Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial.BMJ, 1988
- Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patientsCancer, 1978